WPC
SUPN icon

White Pine Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

White Pine Capital’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,625
Closed -$204K – 210
2023
Q1 		$204K Hold
5,625
– – 0.08% 195
2022
Q4 		$201K Buy
+5,625
New +$195K 0.08% 190
2020
Q3 		– Sell
-8,875
Closed -$211K – 217
2020
Q2 		$211K Sell
8,875
-1,675
-16% -$37K 0.09% 191
2020
Q1 		$190K Hold
10,550
– – 0.1% 182
2019
Q4 		$250K Sell
10,550
-7,000
-40% -$170K 0.1% 193
2019
Q3 		$482K Sell
17,550
-3,360
-16% -$99.6K 0.18% 142
2019
Q2 		$692K Sell
20,910
-625
-3% -$21.4K 0.26% 117
2019
Q1 		$755K Sell
21,535
-6,950
-24% -$259K 0.28% 113
2018
Q4 		$946K Buy
28,485
+3,060
+12% +$132K 0.39% 74
2018
Q3 		$1.28M Hold
25,425
– – 0.45% 65
2018
Q2 		$1.52M Sell
25,425
-450
-2% -$23.3K 0.54% 52
2018
Q1 		$1.19M Sell
25,875
-650
-2% -$27.1K 0.44% 61
2017
Q4 		$1.06M Sell
26,525
-1,640
-6% -$64.8K 0.39% 71
2017
Q3 		$1.13K Sell
28,165
-710
-2% -$30.7K ﹤0.01% 73
2017
Q2 		$1.25M Sell
28,875
-225
-0.8% -$8.01K 0.49% 52
2017
Q1 		$911K Buy
29,100
+150
+0.5% +$4.02K 0.37% 81
2016
Q4 		$731K Buy
28,950
+1,200
+4% +$26.8K 0.31% 95
2016
Q3 		$686K Sell
27,750
-15,350
-36% -$347K 0.29% 94
2016
Q2 		$878K Buy
43,100
+14,825
+52% +$263K 0.37% 74
2016
Q1 		$431K Buy
+28,275
New +$369K 0.18% 149

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

White Pine Capital's SUPN Position: Q2 2023 in Review

White Pine Capital sold out of Supernus Pharmaceuticals (SUPN) in Q2 2023, closing a stake of 5,625 shares — an estimated $204K sold.

White Pine Capital first reported a position in SUPN in Q1 2016 and held it in 20 quarters. The position peaked at $1.52M in Q2 2018. 249 funds tracked by Wall St. Rank hold SUPN as of Q2 2023.

  • White Pine Capital reported no remaining Supernus Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • White Pine Capital sold 5,625 Supernus Pharmaceuticals shares in Q2 2023, an estimated $204K.
  • White Pine Capital first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 20 quarters.
  • White Pine Capital's Supernus Pharmaceuticals position peaked at $1.52M in Q2 2018.
  • 249 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2023.

Based on White Pine Capital's 13F filing for Q2 2023, filed 8 Aug 2023.